Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Influenza

Free Subscription Articles published in Virology Retrieve available abstracts of 145 articles: HTML format

Single Articles

January 2026
1. JOHNSON MG, Strizki JM, Hilbert DW, Zhang Y, et al
   Impact of baseline humoral immunity on treatment outcomes with molnupiravir in the MOVe-OUT randomized, controlled trial.
   Virology. 2026;613:110710.
   PubMed     Abstract available
   
   
   November 2025
2. ZHANG X, Guan L, Wang H, Liu J, et al
   Generation and application of novel DNA aptamers targeted to the nucleocapsid protein of the SARS-CoV-2.
   Virology. 2025;612:110688.
   PubMed     Abstract available
   
   
   
3. ZHANG L, Kempf A, Nehlmeier I, Chen N, et al
   Host cell entry efficiency and neutralization sensitivity of the SARS-CoV-2 MC.10.1 variant.
   Virology. 2025;612:110675.
   PubMed     Abstract available
   
   
   
4. HE Z, Zhang J, Kuang S, Li S, et al
   Colloidal gold technology in viral diagnostics: Recent innovations, clinical applications, and future perspectives.
   Virology. 2025;612:110686.
   PubMed     Abstract available
   
   
   
5. TOBA S, Uemura K, Sanaki T, Kusakabe S, et al
   Synergistic antiviral activity of a cathepsin B/L inhibitor and a TMPRSS2 inhibitor against SARS-CoV-2 in vitro and in vivo.
   Virology. 2025;612:110661.
   PubMed     Abstract available
   
   
   October 2025
6. MELLACE M, Ceniti C, Borrelli L, Tilocca B, et al
   Viral protein mutations enabling mammalian adaptation in Avian Influenza A viruses: Strategies for zoonotic risk mitigation and future perspectives.
   Virology. 2025;614:110731.
   PubMed     Abstract available
   
   
   
7. SEEKINGS AH, Billington E, Mahmood S, Thomas SS, et al
   Infection of point-of-lay hens to assess the sequential events during H7N7 high-pathogenicity avian influenza emergence at a layer premises.
   Virology. 2025;614:110733.
   PubMed     Abstract available
   
   
   
8. WANG A, Hu J, Zhang Q, Zhang Y, et al
   The antiviral activity of interferon-stimulated genes (ISGs) in influenza A virus infection.
   Virology. 2025;614:110728.
   PubMed     Abstract available
   
   
   
9. TSUNEKI-TOKUNAGA A, Komatsu M, Perdana WY, Nishiyama S, et al
   Epidemic influenza virus strains with high growth capability induce severe inflammatory response in vivo.
   Virology. 2025;613:110717.
   PubMed     Abstract available
   
   
   
10. RAVINDRAN C, Mukherjee S
    Zebrafish as a model for SARS-CoV-2 infection, pathogenesis, transmission, and drug screening.
    Virology. 2025;611:110662.
    PubMed     Abstract available
    
    
    
11. LUCINI PAIONI A, Donnici L, Nodari R, Longo Minnolo M, et al
    A rapid and robust luciferase-based reporter system to assess SARS-CoV-2 protease activity.
    Virology. 2025;611:110659.
    PubMed     Abstract available
    
    
    
12. LU CY, Lai PY, Huang JM, Chang LY, et al
    Dual targeting of the Wnt and DNAJB6/MRJ regulatory loop as an anti-RSV strategy.
    Virology. 2025;611:110641.
    PubMed     Abstract available
    
    
    
13. SILVA MO, Daher IP, Oda Ibrahim CH, de Souza EE, et al
    Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.
    Virology. 2025;611:110629.
    PubMed     Abstract available
    
    
    September 2025
14. SMAOUI F, Taktak A, Gargouri S, Chtourou A, et al
    Impact of the COVID-19 pandemic on the molecular epidemiology of respiratory rhinoviruses and enteroviruses in Tunisia.
    Virology. 2025;610:110624.
    PubMed     Abstract available
    
    
    
15. STEGMANN KM, Dickmanns A, Fuchs HL, Scheibner D, et al
    Synergistic interference with SARS-CoV-2 replication by molnupiravir-derived N(4)-hydroxycytidine and inhibitors of CTP synthetase in cell culture.
    Virology. 2025;610:110598.
    PubMed     Abstract available
    
    
    
16. MOTHAE SA, Chiliza TE, Mvubu NE
    SARS-CoV-2 host-pathogen interactome: insights into more players during pathogenesis.
    Virology. 2025;610:110607.
    PubMed     Abstract available
    
    
    
17. SMET M, Berkell M, Gorska A, Tacconelli E, et al
    Drivers of quasispecies development in SARS-CoV-2 and implications for emergent variants and COVID-19.
    Virology. 2025;610:110584.
    PubMed     Abstract available
    
    
    
18. ZHANG MC, Wu H, Wang J, Lu M, et al
    Multi-level inhibition of SARS-CoV-2 invasion by cannabidiol and epigallocatechin gallate.
    Virology. 2025;610:110579.
    PubMed     Abstract available
    
    
    
19. KIM KH, Hwang HS, Lee Y, Jung YJ, et al
    Interferon-gamma receptor signaling is critical for balanced immune activation and protection against influenza after vaccination.
    Virology. 2025;612:110674.
    PubMed     Abstract available
    
    
    August 2025
20. PAWAR SD, Tare DS, Keng SS, Walimbe AM, et al
    Tracing the possible origins of the clade 2.3.4.4b highly pathogenic avian influenza H5Nx viruses from India.
    Virology. 2025 Aug 29:110654. doi: 10.1016/j.virol.2025.110654.
    PubMed     Abstract available
    
    
    
21. QIAO Y, Tang M, Du M, Zhao C, et al
    H5N1 influenza virus-like particles based on BEVS induce robust functional antibodies and immune responses.
    Virology. 2025;612:110672.
    PubMed     Abstract available
    
    
    
22. CHINNA P, Blumenthal MJ, Lambarey H, Jennings L, et al
    Assessment of gamma-herpesvirus infection dynamics in non-hospitalised people living with HIV during the COVID-19 pandemic in South Africa.
    Virology. 2025;611:110666.
    PubMed     Abstract available
    
    
    
23. BADR C, Arbi M, Souiai O, Larbi I, et al
    Tracing the 2021 equine influenza Outbreak: First characterization and phylogeographic analysis of H3N8 Florida clade 1 virus in Tunisia.
    Virology. 2025;611:110655.
    PubMed     Abstract available
    
    
    July 2025
24. EBRAHIMI N, Sadeh S, Ghaemi A
    Is HA0-Mediated heat resistance in influenza a food safety concern? A methodological critique.
    Virology. 2025 Jul 29:110643. doi: 10.1016/j.virol.2025.110643.
    PubMed     Abstract available
    
    
    
25. CHERNYSHOVA AI, Zhirnov OP
    Influenza A virions with uncleaved hemagglutinin HA0 are more resistant to thermal inactivation than those with cleaved HA1/2: Research and applied significance.
    Virology. 2025 Jul 26:110644. doi: 10.1016/j.virol.2025.110644.
    PubMed    
    
    
    
26. FENG X, Yang X, Hu X, Liu Q, et al
    The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.
    Virology. 2025;611:110642.
    PubMed     Abstract available
    
    
    
27. HU X, Gao M, Ren X, An L, et al
    Effects of synonymous codons with optimization / deoptimization in nucleoprotein (NP) gene of influenza A virus on interaction between NP and tripartite motif protein 25 (TRIM25).
    Virology. 2025;610:110626.
    PubMed     Abstract available
    
    
    
28. LIU R, Song F, Sun L, Yan F, et al
    Exploring the pathogenic and transmission characteristics of JN.1 in golden hamsters based on different attack methods.
    Virology. 2025;608:110548.
    PubMed     Abstract available
    
    
    
29. CAO L, Shi S, Zhang C, Zhao C, et al
    A phycobiliprotein-based reporter assay for the evaluation of SARS-CoV-2 main protease activity.
    Virology. 2025;608:110540.
    PubMed     Abstract available
    
    
    June 2025
30. MEMOLI MJ, Tumpey TM, Jagger BW, Dugan VG, et al
    Corrigendum to: An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice [Virology, volume 393/2 (2009) 539, 338 - 345.
    Virology. 2025 Jun 28:110611. doi: 10.1016/j.virol.2025.110611.
    PubMed    
    
    
    
31. PASQUALE S, Moscara L, Palmieri C, Martinelli A, et al
    Safety of SARS-CoV-2 XBB.1.5 and seasonal influenza vaccines co-administration: data from a perspective observational active surveillance study. Puglia (Italy), season 2023/2024.
    Virology. 2025;610:110613.
    PubMed     Abstract available
    
    
    
32. FENG S, Huang M, Quan Y, Sun L, et al
    The spike 486 site is a key immune evasion point and a determinant of the immunogenicity of the RBD-dimer mRNA vaccine against SARS-CoV-2 variants.
    Virology. 2025;610:110612.
    PubMed     Abstract available
    
    
    
33. NGUYEN XD, Le B, Yang Q, Wang B, et al
    PathoSift Pro: A novel size-based bioaerosol sampler for effectively detecting infectious airborne influenza virus.
    Virology. 2025;610:110609.
    PubMed     Abstract available
    
    
    
34. BRUNO A, de Mora D, Olmedo M, Garces J, et al
    Highly pathogenic avian influenza A (H5N1) virus outbreaks in South America in 2022-2024: a comprehensive review of an ongoing panzootic.
    Virology. 2025;610:110602.
    PubMed     Abstract available
    
    
    
35. TABYNOV K, Kuanyshbek A, Zharmambet K, Yelchibayeva L, et al
    Evaluation of commercial vaccines for efficacy and transmission control against the emergent H5N8 (clade 2.3.4.4b) avian influenza virus in Kazakhstan.
    Virology. 2025;610:110601.
    PubMed     Abstract available
    
    
    
36. CHAKRABORTY C, Bhattacharya M, Abdelhameed AS
    Recent SARS-CoV-2 evolution trajectories indicate the emergence of Omicron's several subvariants and the current rise of KP.3.1.1 and XEC.
    Virology. 2025;607:110508.
    PubMed     Abstract available
    
    
    
37. ANDERSON M, Lopez J, Wyr M, Ramirez PW, et al
    Defining diverse spike-receptor interactions involved in SARS-CoV-2 entry: Mechanisms and therapeutic opportunities.
    Virology. 2025;607:110507.
    PubMed     Abstract available
    
    
    
38. BEAUDOIN-BUSSIERES G, Tauzin A, Dionne K, El Ferri O, et al
    Multiple exposures to SARS-CoV-2 Spike enhance cross-reactive antibody-dependent cellular cytotoxicity against SARS-CoV-1.
    Virology. 2025;607:110512.
    PubMed     Abstract available
    
    
    May 2025
39. LENDE SSF, Rothemejer FH, Andreas M, Pedersen ML, et al
    Vectored long-term co-delivery of antibodies for SARS-CoV-2, RSV and Influenza prophylaxis.
    Virology. 2025;610:110573.
    PubMed     Abstract available
    
    
    
40. ISHIGAKI H, Itoh Y
    Translational research on pandemic virus infection using nonhuman primate models.
    Virology. 2025;606:110511.
    PubMed     Abstract available
    
    
    
41. DAS SARMA J
    Murine beta-coronavirus spike protein: A major determinant of neuropathogenic properties.
    Virology. 2025;606:110499.
    PubMed     Abstract available
    
    
    
42. LUNDRIGAN E, Uguccioni S, Hum C, Ahmed N, et al
    SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways.
    Virology. 2025;606:110493.
    PubMed     Abstract available
    
    
    April 2025
43. REUSS D, Brown JC, Sukhova K, Furnon W, et al
    Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epithelium.
    Virology. 2025;608:110556.
    PubMed     Abstract available
    
    
    March 2025
44. RAHA JR, Kim KH, Tien Le CT, Bhatnagar N, et al
    A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e.
    Virology. 2025;606:110510.
    PubMed     Abstract available
    
    
    
45. BANGA NDZOUBOUKOU JL, Kamara AA, Ullah N, Lei Q, et al
    A meta-analysis on the immunogenicity of prototype, monovalent-adapted and bivalent vaccines against SARS-CoV-2 wildtype, Omicron BA.1 and Omicron BA.4/5 in healthy adults.
    Virology. 2025;606:110509.
    PubMed     Abstract available
    
    
    
46. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    PubMed     Abstract available
    
    
    
47. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    PubMed     Abstract available
    
    
    
48. LAI SK, Lee ZQ, Tan TI, Tan BH, et al
    Evidence that the cell glycocalyx envelops respiratory syncytial virus (RSV) particles that form on the surface of RSV-infected human airway cells.
    Virology. 2025;604:110415.
    PubMed     Abstract available
    
    
    
49. HILLS FR, Geoghegan JL, Bostina M
    Architects of infection: A structural overview of SARS-related coronavirus spike glycoproteins.
    Virology. 2025;604:110383.
    PubMed     Abstract available
    
    
    
50. PORTER SM, Hartwig AE, Quilici M, Bosco-Lauth AM, et al
    Intraspecific SARS-CoV-2 Delta variant transmission among red fox (Vulpes vulpes) and striped skunk (Mephitis mephitis).
    Virology. 2025;604:110446.
    PubMed     Abstract available
    
    
    
51. HE M, He CQ, Ding NZ
    Human viruses: An ever-increasing list.
    Virology. 2025;604:110445.
    PubMed     Abstract available
    
    
    
52. SHI H, Inankur B, Yin J
    Serum starvation impacts rhinovirus spread from cell to cell.
    Virology. 2025;604:110408.
    PubMed     Abstract available
    
    
    
53. SUGRUE RJ, Tan BH
    The link between respiratory syncytial virus (RSV) morphogenesis and virus transmission: Towards a paradigm for understanding RSV transmission in the upper airway.
    Virology. 2025;604:110413.
    PubMed     Abstract available
    
    
    
54. YAMAMOTO A, Ito H, Sakaguchi T, Higashiura A, et al
    Structural insights into nucleocapsid protein variability: Implications for PJ34 efficacy against SARS-CoV-2.
    Virology. 2025;604:110411.
    PubMed     Abstract available
    
    
    February 2025
55. BENLARBI M, Kenfack DD, Dionne K, Cote-Chenette M, et al
    Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.
    Virology. 2025;605:110467.
    PubMed     Abstract available
    
    
    
56. HARADA R, Hiono T, Igarashi M, Kobayashi D, et al
    Altered receptor-binding specificity of gull-adapted H13 avian influenza viruses corresponds to their unique host preferences.
    Virology. 2025;605:110460.
    PubMed     Abstract available
    
    
    
57. MILLER JL, Niewiesk S
    Review of impaired immune parameters in RSV infections in the elderly.
    Virology. 2025;603:110395.
    PubMed     Abstract available
    
    
    
58. JONES LR
    Intra-host variability of SARS-CoV-2: Patterns, causes and impact on COVID-19.
    Virology. 2025;603:110366.
    PubMed     Abstract available
    
    
    
59. ROY K, Saikia BK, Konwar R
    Exploring the role of carbon quantum dots as countermeasure for SARS-CoV-2 virus.
    Virology. 2025;603:110339.
    PubMed     Abstract available
    
    
    
60. POPOVIC ME, Tadic V, Popovic M
    (R)evolution of Viruses: Introduction to biothermodynamics of viruses.
    Virology. 2025;603:110319.
    PubMed     Abstract available
    
    
    January 2025
61. FRAGOSO-SAAVEDRA M, Liu Q
    Towards developing multistrain PEDV vaccines: Integrating basic concepts and SARS-CoV-2 pan-sarbecovirus strategies.
    Virology. 2025;604:110412.
    PubMed     Abstract available
    
    
    
62. PATEL H, Kukol A
    Harnessing viral internal proteins to combat flu and beyond.
    Virology. 2025;604:110414.
    PubMed     Abstract available
    
    
    
63. HASSAN MSH, Sharif S
    Immune responses to avian influenza viruses in chickens.
    Virology. 2025;603:110405.
    PubMed     Abstract available
    
    
    
64. NI M, Lin S, Shao Y, Tang J, et al
    Enteric pathogenicity characterization of emerging parainfluenza virus 5 in western China.
    Virology. 2025;604:110409.
    PubMed     Abstract available
    
    
    
65. ZHAO Y, Li W, Xu L, Tao Z, et al
    Antibody responses in omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2.
    Virology. 2025;603:110404.
    PubMed     Abstract available
    
    
    
66. SAHA A, Choudhary S, Walia P, Kumar P, et al
    Transformative approaches in SARS-CoV-2 management: Vaccines, therapeutics and future direction.
    Virology. 2025;604:110394.
    PubMed     Abstract available
    
    
    
67. LV X, Zheng T, Lei X, Ren L, et al
    RTP4 restricts influenza A virus infection by targeting the viral NS1 protein.
    Virology. 2025;603:110397.
    PubMed     Abstract available
    
    
    
68. ZHIRNOV OP, Chernyshova AI
    The uncleaved viral hemagglutinin HA0 increases influenza A virus resistance to thermal pasteurization.
    Virology. 2025;604:110389.
    PubMed     Abstract available
    
    
    
69. SULTANA R, Stahelin RV
    Strengths and limitations of SARS-CoV-2 virus-like particle systems.
    Virology. 2025;601:110285.
    PubMed     Abstract available
    
    
    December 2024
70. CALDERON-PEREZ B, Nunez-Munoz LA, Trejo-Ayala LL, Rosales-Garcia VH, et al
    Immunogenicity of a multivalent protein subunit vaccine based on non-glycosylated RBD antigens of SARS-cov-2 and its variants.
    Virology. 2024;603:110380.
    PubMed     Abstract available
    
    
    
71. MCKENNA S, Jung KI, Wolf JJ, Seo YJ, et al
    Multiple sphingolipid-metabolizing enzymes modulate influenza virus replication.
    Virology. 2024;603:110367.
    PubMed     Abstract available
    
    
    
72. OO A, Chen Z, Cao D, Cho YJ, et al
    Biochemical simulation of mutation synthesis and repair during SARS-CoV-2 RNA polymerization.
    Virology. 2024;600:110255.
    PubMed     Abstract available
    
    
    
73. NOWAK R, Gazecka M, Hoffmann M, Kierzek R, et al
    TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses.
    Virology. 2024;600:110218.
    PubMed     Abstract available
    
    
    
74. WANG C, Zhang Y, Yang C, Ren W, et al
    Receptor binding mechanism and immune evasion capacity of SARS-CoV-2 BQ.1.1 lineage.
    Virology. 2024;600:110241.
    PubMed     Abstract available
    
    
    
75. WANG M, Valadez-Ingersoll M, Gilmore TD
    Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2.
    Virology. 2024;600:110232.
    PubMed     Abstract available
    
    
    November 2024
76. YANG S, Yang X, Zhu W, Luo C, et al
    The novel COVID-19 treatment VV116 is a potential inhibitor of Zika virus.
    Virology. 2024;603:110334.
    PubMed     Abstract available
    
    
    
77. KEGEL NB, Kaufmann A, Matrosovich M, Bauer S, et al
    Decomposition of L-glutamine and accumulation of ammonium in cell culture media inhibit infectivity of influenza viruses.
    Virology. 2024;602:110314.
    PubMed     Abstract available
    
    
    
78. ZHAO Q, Zhang J, Yang S, Bai X, et al
    H1N1 swine influenza viruses upregulate NEU1 expression through histone H3 acetylation regulated by HDAC2.
    Virology. 2024;601:110305.
    PubMed     Abstract available
    
    
    October 2024
79. WU Y, Lai SK, En-Zuo Chan C, Tan BH, et al
    Evidence that the SARS-CoV-2 S protein undergoes a conformational change at the Golgi complex that leads to the formation of virus neutralising antibody binding epitopes in the S1 protein subunit.
    Virology. 2024;598:110187.
    PubMed     Abstract available
    
    
    September 2024
80. LIU J, Chen K, Wu W, Pang Z, et al
    GRP78 exerts antiviral function against influenza A virus infection by activating the IFN/JAK-STAT signaling.
    Virology. 2024;600:110249.
    PubMed     Abstract available
    
    
    
81. CHAKRABORTY C, Bhattacharya M
    Evolution and mutational landscape of highly pathogenic avian influenza strain A(H5N1) in the current outbreak in the USA and global landscape.
    Virology. 2024;600:110246.
    PubMed     Abstract available
    
    
    
82. BENITO AA, Monteagudo LV, Lazaro-Gaspar S, Mazas-Cabetas L, et al
    Detection and subtyping of influenza A virus in porcine clinical samples from Spain in 2020.
    Virology. 2024;600:110223.
    PubMed     Abstract available
    
    
    
83. ROOT JJ, Porter SM, Lenoch JB, Ellis JW, et al
    Susceptibilities and viral shedding of peridomestic wildlife infected with clade 2.3.4.4b highly pathogenic avian influenza virus (H5N1).
    Virology. 2024;600:110231.
    PubMed     Abstract available
    
    
    
84. LEI Y, Xu N, Niu C, Chen L, et al
    Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
    Virology. 2024;597:110142.
    PubMed     Abstract available
    
    
    
85. LIANG Z, Wang J, Zhang H, Gao L, et al
    Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Virology. 2024;597:110149.
    PubMed     Abstract available
    
    
    
86. DUDEK I, Czerkies M, Kwiatek A
    Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
    Virology. 2024;597:110127.
    PubMed     Abstract available
    
    
    August 2024
87. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
    Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
    Virology. 2024;596:110118.
    PubMed     Abstract available
    
    
    July 2024
88. MANDVIWALA AS, Huckriede ALW, Arankalle VA, Patil HP, et al
    Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice.
    Virology. 2024;598:110194.
    PubMed     Abstract available
    
    
    
89. CAI M, Wei Z, Hu X, Ji Y, et al
    The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
    Virology. 2024;598:110167.
    PubMed     Abstract available
    
    
    
90. LIU J, Ren T, Wang X, Wang H, et al
    The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China.
    Virology. 2024;597:110157.
    PubMed     Abstract available
    
    
    
91. LEE J, Naoe Y, Bang U, Nakagama Y, et al
    Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
    Virology. 2024;595:110067.
    PubMed     Abstract available
    
    
    
92. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
    Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
    Virology. 2024;595:110082.
    PubMed     Abstract available
    
    
    
93. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
    Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
    Virology. 2024;595:110068.
    PubMed     Abstract available
    
    
    June 2024
94. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    PubMed     Abstract available
    
    
    
95. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    PubMed     Abstract available
    
    
    
96. NGUYEN CT, Nakayama M, Ishigaki H, Kitagawa Y, et al
    Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
    Virology. 2024;594:110052.
    PubMed     Abstract available
    
    
    
97. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    PubMed     Abstract available
    
    
    May 2024
98. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    PubMed     Abstract available
    
    
    
99. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    PubMed     Abstract available
    
    
    
100. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
     Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
     Virology. 2024;596:110117.
     PubMed     Abstract available
     
     
     
101. HUANG J, Ma K, Zhang J, Zhou J, et al
     Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
     Virology. 2024;597:110121.
     PubMed     Abstract available
     
     
     
102. SAIKIA BK, Roy K, Konwar R
     Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
     Virology. 2024;593:110036.
     PubMed     Abstract available
     
     
     
103. LIU J, Gao L, Zhou N, Jiang Z, et al
     p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
     Virology. 2024;593:110018.
     PubMed     Abstract available
     
     
     April 2024
104. MA X, Wang Q, Xu X, Zhang W, et al
     miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
     Virology. 2024;595:110094.
     PubMed     Abstract available
     
     
     
105. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
     Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
     Virology. 2024;595:110097.
     PubMed     Abstract available
     
     
     
106. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
     A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
     Virology. 2024;592:109997.
     PubMed     Abstract available
     
     
     
107. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
     The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
     Virology. 2024;592:109986.
     PubMed     Abstract available
     
     
     March 2024
108. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
     Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
     Virology. 2024;595:110066.
     PubMed     Abstract available
     
     
     
109. SAKA N, Nishio M, Ohta K
     Human parainfluenza virus type 2 V protein inhibits mitochondrial apoptosis pathway through two ways.
     Virology. 2024;594:110053.
     PubMed     Abstract available
     
     
     
110. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
     Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
     Virology. 2024;594:110050.
     PubMed     Abstract available
     
     
     
111. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
     Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
     Virology. 2024;591:109985.
     PubMed     Abstract available
     
     
     February 2024
112. HUANG Y, Zhang P, Han S, Hu B, et al
     Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
     Virology. 2024;593:110031.
     PubMed     Abstract available
     
     
     
113. MA B, Tao M, Li Z, Zheng Q, et al
     Mucosal vaccines for viral diseases: Status and prospects.
     Virology. 2024;593:110026.
     PubMed     Abstract available
     
     
     
114. YANG J, Lan R, Chang H, Li H, et al
     Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza virus in pigs suffering from pneumonia.
     Virology. 2024;592:110009.
     PubMed     Abstract available
     
     
     
115. LEE DW, Kim JM, Kim DW, Kim JY, et al
     Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern.
     Virology. 2024;590:109945.
     PubMed     Abstract available
     
     
     January 2024
116. FANG K, Song W, Zhang Y, Zheng Y, et al
     Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
     Virology. 2024;592:109995.
     PubMed     Abstract available
     
     
     
117. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
     A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
     Virology. 2024;592:109996.
     PubMed     Abstract available
     
     
     
118. ZHANG Y, Wang D, Xiang Q, Hu X, et al
     A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
     Virology. 2024;589:109925.
     PubMed     Abstract available
     
     
     December 2023
119. TANG C, Carrera Montoya J, Fritzlar S, Flavel M, et al
     Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
     Virology. 2023;590:109969.
     PubMed     Abstract available
     
     
     
120. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
     Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
     Virology. 2023;590:109954.
     PubMed     Abstract available
     
     
     November 2023
121. RAMEY AM, Scott LC, Ahlstrom CA, Buck EJ, et al
     Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska.
     Virology. 2023;589:109938.
     PubMed     Abstract available
     
     
     
122. ZHU M, Zeng H, He J, Zhu Y, et al
     Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice.
     Virology. 2023;589:109927.
     PubMed     Abstract available
     
     
     
123. NAIQING X, Tang X, Wang X, Cai M, et al
     Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus.
     Virology. 2023;589:109926.
     PubMed     Abstract available
     
     
     October 2023
124. AFRIN SZ, Sathi FA, Nooruzzaman M, Parvin R, et al
     Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
     Virology. 2023;587:109882.
     PubMed     Abstract available
     
     
     September 2023
125. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
     SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
     Virology. 2023;586:122-129.
     PubMed     Abstract available
     
     
     
126. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
     In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
     Virology. 2023;586:115-121.
     PubMed     Abstract available
     
     
     
127. XIAO Y, Wang L, Fang SS, Luo F, et al
     Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
     Virology. 2023;586:105-114.
     PubMed     Abstract available
     
     
     August 2023
128. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
     AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
     Virology. 2023;587:109875.
     PubMed     Abstract available
     
     
     
129. UPRETY T, Sreenivasan CC, Thomas M, Hause B, et al
     Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex.
     Virology. 2023;587:109859.
     PubMed     Abstract available
     
     
     
130. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
     H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
     Virology. 2023;587:109860.
     PubMed     Abstract available
     
     
     
131. MARANO JM, Cereghino C, Finkielstein CV, Weger-Lucarelli J, et al
     An in vitro workflow to create and modify infectious clones using replication cycle reaction.
     Virology. 2023;585:109-116.
     PubMed     Abstract available
     
     
     
132. SILVA JUNIOR JVJ, Duraes-Carvalho R, de Souza JR, Ramos Janini LM, et al
     Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
     Virology. 2023;585:78-81.
     PubMed     Abstract available
     
     
     July 2023
133. ZHOU H, Liu J, Li L, Sun J, et al
     Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
     Virology. 2023;587:109855.
     PubMed     Abstract available
     
     
     June 2023
134. TANG L, Liu X, Wang C, Shu C, et al
     USP18 promotes innate immune responses and apoptosis in influenza A virus-infected A549 cells via cGAS-STING pathway.
     Virology. 2023;585:240-247.
     PubMed     Abstract available
     
     
     
135. SU R, Shi Z, Li E, Zhu M, et al
     A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
     Virology. 2023;585:145-154.
     PubMed     Abstract available
     
     
     
136. YILMAZ B, Cakmak Genc G, Karakas Celik S, Piskin N, et al
     The 3'UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs.
     Virology. 2023;583:29-35.
     PubMed     Abstract available
     
     
     
137. POTTAGE T, Onianwa O, Atkinson B, Spencer A, et al
     Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature.
     Virology. 2023;583:27-28.
     PubMed     Abstract available
     
     
     
138. PFANZAGL B
     The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes.
     Virology. 2023;583:45-51.
     PubMed     Abstract available
     
     
     May 2023
139. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
     Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
     Virology. 2023;584:38-43.
     PubMed     Abstract available
     
     
     
140. SUN X, Belser JA, Kieran TJ, Brock N, et al
     Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.
     Virology. 2023;582:57-61.
     PubMed     Abstract available
     
     
     
141. MAYER AM, Grohs Ferrareze PA, de Oliveira LFV, Gregianini TS, et al
     Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil.
     Virology. 2023;582:1-11.
     PubMed     Abstract available
     
     
     April 2023
142. BOSCO-LAUTH A, Rodriguez A, Maison RM, Porter SM, et al
     H7N9 influenza A virus transmission in a multispecies barnyard model.
     Virology. 2023;582:100-105.
     PubMed     Abstract available
     
     
     
143. KANDWAL S, Fayne D
     Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
     Virology. 2023;581:97-115.
     PubMed     Abstract available
     
     
     March 2023
144. HUONG TN, Ravi Iyer L, Lui J, Wang Y, et al
     The respiratory syncytial virus SH protein is incorporated into infectious virus particles that form on virus-infected cells.
     Virology. 2023;580:28-40.
     PubMed     Abstract available
     
     
     October 2022
145. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
     A live single-cycle RSV vaccine expressing prefusion F protein.
     Virology. 2022;577:51-64.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.